Intus Biosciences, LLC is a cutting-edge biotechnology company based in Farmington, CT. Their Titan-1 platform revolutionizes microbiome research by utilizing a patented assay and proprietary Artificial Intelligence (AI) tools, enabling powerful insights and discoveries beyond the capabilities of traditional 16S and shotgun metagenomics technologies. Collaborating with pharma, academic organizations, and commercial lab partners, Intus Bio's technology is deployed for drug development, biomarker discovery, and patient care, addressing a wide range of therapeutic and diagnostic purposes.
What sets Intus Bio apart is their breakthrough data analysis approach, combining high-resolution, high-throughput Titan-1 assay with advanced AI analysis to generate accurate and actionable information. Unlike other technologies, Intus Bio's platform produces strain-level data at scale, allowing for the identification and tracking of specific strains, which is crucial for drug response, disease diagnosis, and understanding the microbiome. With their proven, proprietary technology, Intus Bio delivers unmatched results, making significant contributions to the field of microbiome research.
Generated from the website